SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Sean Janzen who wrote ()6/13/1996 2:45:00 PM
From: Sean Janzen   of 1501
 
The following table illustrates Inflazyme's most advanced technologies and corporate strategy for their development.

-------Technology------------Strategy--------Year------Partner
TB-antigen for diagnostic-Licensed-out-----1996-----Abbott Lab
Phosphonate-anti-tumour---License-out------1996-----pharma
TB-Antigen for vaccine----License-out-----1996/97---major vaccine Co.
Apanol (anti-asthma drug)-Joint Venture----1996---- Large Pharma Co.
Tiesol (anti-allergy drug-Joint Venture---1996/97---Large Pharma Co.
Bispan (anti-arthritis drug-License-out---1996/97---Large Pharma Co.

Does this looks promising? If you think these developments look interesting check out Inflazyme at: stockprofiles.com . I think they have a quality web page and they keep current on news releases. Let me know what you think!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext